Clinical Trials Logo

Local Disease clinical trials

View clinical trials related to Local Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT04213664 Recruiting - Clinical trials for Renal Cell Carcinoma

Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.

LMR
Start date: December 31, 2019
Phase:
Study type: Observational

PubMed, ScienceDirect, Cochrane Database of Systematic Reviews will be used to search for articles published from January 1965 to July 2019 using the key words "renal cancer", "lymphocyte to monocyte ratio" and "prognosis". No restrictions to date, language, or article type will be applied. Cohort or observational studies in patients with non-metastatic renal cell carcinoma histopathologically confirmed, with hazard ratios (HR) and corresponding 95% confidence intervals (CI) that assessed association between LMR and overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and disease-free survival (DFS) will be analyzed.

NCT ID: NCT01764646 Active, not recruiting - Clinical trials for Malignant Neoplasm of Prostate

Hypofractionated Radiation Therapy in Prostate Cancer

Start date: September 2012
Phase: N/A
Study type: Interventional

RATIONALE: It is not yet known whether extreme hypofractionation is equally safe and effective than standard radiation therapy in treating prostate cancer. PURPOSE: This protocol presents a randomised phase II study aiming to investigate the tolerance and disease control of extreme hypofractionated Radiation Therapy for prostate cancer.